Perspective - (2025) Volume 13, Issue 3
Received: 02-Jun-2025, Manuscript No. jcdd-25-176796;
Editor assigned: 04-Jun-2025, Pre QC No. P-176796;
Reviewed: 18-Jun-2025, QC No. Q-176796;
Revised: 23-Jun-2025, Manuscript No. R-176796;
Published:
30-Jun-2025
, DOI: 10.37421/2329-9517.2025.13.676
Citation: Jovanovic, Nina. ”Dyspnea: Etiology, Evaluation, and
Comprehensive Management.” J Cardiovasc Dis Diagn 13 (2025):676.
Copyright: © 2025 Jovanovic N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and source are credited.Jovanovic, Nina. ”Dyspnea: Etiology, Evaluation, and
Comprehensive Management.” J Cardiovasc Dis Diagn 13 (2025):676.
Shortness of breath, known medically as dyspnea, is a complex symptom often reflecting underlying cardiorespiratory conditions or even systemic diseases. Understanding its pathophysiology involves considering various neural pathways and receptor activations. Proper diagnosis necessitates a thorough patient history, physical examination, and targeted investigations. Management strategies are multifaceted, ranging from addressing the root cause to symptomatic relief, often tailored to individual patient needs and the severity of their condition [1].
When someone arrives at the emergency department with acute shortness of breath, rapid and accurate evaluation is critical. The initial assessment focuses on stabilizing the patient and identifying life-threatening causes. This involves a systematic approach, often combining clinical findings with targeted diagnostics like ECG, chest X-ray, and blood tests. Effective management depends on correctly identifying the underlying etiology, from cardiac events to pulmonary embolisms, and initiating appropriate, timely interventions [2].
For individuals living with chronic shortness of breath, especially when underlying diseases are no longer curable, palliative care plays a crucial role. This approach focuses on improving quality of life by managing symptoms and providing holistic support. Non-pharmacological interventions like breathing techniques, oxygen therapy (when indicated), and exercise, alongside pharmacological treatments such as opioids, are often employed to alleviate the distressing sensation of dyspnea and enhance comfort [3].
The COVID-19 pandemic brought a unique spotlight on shortness of breath as a primary and often debilitating symptom. This review delves into the mechanisms behind COVID-19-related dyspnea, which can range from direct viral lung injury to systemic inflammation and anxiety. Effective management involves supportive care, including oxygen therapy and ventilation strategies, as well as addressing underlying factors. Understanding these dynamics has been crucial for patient care throughout the pandemic [4].
Identifying the root cause of shortness of breath is fundamental to effective treatment. This article outlines a systematic approach to diagnosing dyspnea, emphasizing the importance of differentiating between cardiac, pulmonary, and other systemic etiologies. Diagnostic strategies often involve a combination of clinical assessment, imaging studies like chest radiography and CT scans, and specialized physiological tests, all aimed at pinpointing the specific condition driving the symptom [5].
Accurately assessing shortness of breath is crucial for guiding treatment and monitoring patient progress. This article explores various methods, ranging from simple subjective scales used at the bedside, like the Modified Medical Research Council (mMRC) scale, to more objective physiological measurements in a laboratory setting. Integrating these assessment tools provides a comprehensive understanding of a patient's dyspnea experience, helping clinicians tailor interventions more effectively [6].
While non-pharmacological approaches are important, certain medications can offer significant relief for severe or refractory shortness of breath. This review explores the range of pharmacological options available, including opioids, benzodiazepines, and bronchodilators, discussing their efficacy, potential side effects, and appropriate indications. The goal is to provide clinicians with a comprehensive overview to guide individualized treatment plans, particularly in palliative care settings where symptom control is paramount [7].
Beyond medications, several non-pharmacological interventions prove beneficial for chronic shortness of breath, especially in those with chronic respiratory diseases. This umbrella review highlights the evidence for strategies like pulmonary rehabilitation, breathing exercises, fan therapy, and psychological support. These approaches empower patients to better manage their symptoms, reduce anxiety, and improve their overall functional capacity, offering a holistic pathway to symptom relief [8].
Shortness of breath is a hallmark symptom of heart failure, significantly impacting quality of life. This article explores how impaired cardiac function leads to dyspnea through mechanisms like pulmonary congestion and reduced oxygen delivery. It emphasizes the need for a patient-centered approach to management, integrating pharmacological therapies, lifestyle modifications, and education to alleviate symptoms and improve functional capacity, ultimately aiming for better patient outcomes [9].
Shortness of breath presents unique challenges in older adults due to age-related physiological changes, multiple comorbidities, and often atypical symptom presentations. This review highlights common etiologies in this population, including cardiac, pulmonary, and neuromuscular causes, and discusses tailored assessment strategies. Effective management requires a comprehensive approach, considering polypharmacy and functional status, with an emphasis on improving comfort and maintaining independence [10].
Dyspnea, commonly known as shortness of breath, is a complex and often distressing symptom arising from various underlying cardiorespiratory and systemic conditions [1]. Unpacking its pathophysiology requires looking at neural pathways and receptor activations. A solid diagnosis starts with a thorough patient history, a good physical exam, and specific investigations. Management is multifaceted, ranging from fixing the root cause to simply relieving symptoms, always tailored to what each patient needs and how severe their condition is [1]. Accurately assessing dyspnea is crucial for guiding treatment and tracking patient improvement. We use various methods, everything from simple subjective scales at the bedside, like the Modified Medical Research Council (mMRC) scale, to more exact physiological measurements done in a lab. Combining these assessment tools gives clinicians a full picture of a patient's dyspnea experience, helping them create more effective interventions [6].
When someone comes into the emergency department with acute shortness of breath, rapid and precise evaluation is absolutely critical [2]. The first thing is always to stabilize the patient and figure out if anything life-threatening is going on. This means a systematic approach, often mixing clinical observations with targeted diagnostic tests like an Electrocardiogram (ECG), chest X-ray, and blood work. Good management really depends on correctly pinpointing the underlying issue, whether it's a heart attack or a pulmonary embolism, and then getting the right treatments started right away [2]. Identifying the exact cause of shortness of breath is fundamental for effective treatment. We use a systematic way to diagnose dyspnea, making sure to tell the difference between cardiac, pulmonary, and other systemic causes. Diagnostic plans often combine clinical assessment, imaging studies like chest radiography and Computerized Tomography (CT) scans, plus specialized physiological tests, all aimed at finding the specific condition driving the symptom [5].
For folks living with chronic shortness of breath, especially when their underlying diseases can't be cured, palliative care really steps up. This approach is all about improving quality of life by managing symptoms and offering holistic support [3]. Non-pharmacological interventions like breathing techniques, oxygen therapy (if needed), and exercise are often used. You also see pharmacological treatments, like opioids, to ease the distressing feeling of dyspnea and boost comfort [3]. Beyond medications, several non-pharmacological interventions prove helpful for chronic shortness of breath, especially for those with ongoing respiratory diseases. An umbrella review highlights the evidence for strategies like pulmonary rehabilitation, breathing exercises, fan therapy, and psychological support. These methods empower patients to better manage their symptoms, lessen anxiety, and improve their overall functional capacity, providing a holistic path to symptom relief [8].
While non-pharmacological methods are important, certain medications can offer significant relief for severe or difficult-to-treat shortness of breath [7]. This review looks at pharmacological options, including opioids, benzodiazepines, and bronchodilators, discussing how well they work, their potential side effects, and when they are appropriate. The goal is to give clinicians a full overview to guide individualized treatment plans, particularly in palliative care where symptom control is key [7]. The COVID-19 pandemic really put a spotlight on shortness of breath as a main and often debilitating symptom. The mechanisms behind COVID-19-related dyspnea can vary from direct viral lung injury to widespread inflammation and anxiety. Effective management involves supportive care, including oxygen therapy and ventilation strategies, along with addressing underlying issues. Understanding these dynamics was crucial for patient care throughout the pandemic [4].
Shortness of breath is a classic symptom of heart failure, and it really impacts quality of life [9]. This article explores how poor heart function leads to dyspnea through things like pulmonary congestion and less oxygen getting to tissues. It stresses the need for a patient-centered management approach, combining drug therapies, changes in lifestyle, and education to ease symptoms and improve how well patients can function, ultimately aiming for better outcomes [9]. Shortness of breath presents unique difficulties in older adults because of age-related body changes, multiple health problems, and symptoms that often aren't typical. This review points out common causes in this group, including heart, lung, and nerve-muscle issues, and talks about specific assessment strategies. Effective management needs a broad approach, thinking about multiple medications and how well the person can function, with a big focus on improving comfort and keeping their independence [10].
Dyspnea, or shortness of breath, is a complex symptom rooted in various cardiorespiratory and systemic conditions, demanding a thorough understanding of its pathophysiology for proper diagnosis and tailored management. Effective evaluation involves patient history, physical examination, and targeted investigations. In acute settings like the emergency department, rapid assessment is crucial to stabilize patients and identify life-threatening causes, utilizing diagnostics such as ECG and imaging to guide timely interventions. For chronic dyspnea, particularly in advanced diseases, palliative care focuses on enhancing quality of life through symptom management, employing both non-pharmacological methods like breathing techniques and exercise, alongside pharmacological options like opioids. The COVID-19 pandemic highlighted dyspnea's role, with its mechanisms spanning viral injury to systemic inflammation, necessitating supportive care and targeted therapies. Pinpointing the specific etiologyâ??be it cardiac, pulmonary, or other systemic issuesâ??is fundamental, often involving a combination of clinical assessment, imaging, and physiological tests. Assessing dyspnea ranges from subjective scales at the bedside to objective laboratory measurements, offering a comprehensive view for personalized interventions. Pharmacological treatments, including opioids and bronchodilators, provide significant relief for severe cases, especially in palliative care, while non-pharmacological strategies like pulmonary rehabilitation and psychological support empower patients with chronic respiratory conditions to manage symptoms and improve functional capacity. Special populations, like individuals with heart failure, experience dyspnea due to impaired cardiac function, requiring patient-centered care that integrates medication, lifestyle adjustments, and education. Older adults present unique challenges due to age-related changes and comorbidities, necessitating a comprehensive management approach focused on comfort and independence.
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report
